LEmed Have Announced Three Double Technology Centers are Now Available

LEmed, the specialist stem cell and laser therapy research and distribution group, and T-cell
Modulator (TCM) research and distribution group, announced today that it has established a third
new Double Clinic.
Wan Chai, Hong Kong, November !, "#$ %% LEmed (Leading Edge Medical Ltd.), the specialist
stem cell and laser therapy research and distribution group, and T-cell Modulator (TCM) research
and distribution group, announced today that it has established a third new Double Clinic or
patients suering rom chronic diseases which standard medicine cannot help.
The latest and most promising o these therapies is the use o TCM! --- a proprietary immuno-
regulatory product designed speciically to train and stimulate a patients own immune system in
order to more eiciently and successully deal with a wide range o health conditions.
Don Margolis, ounder and chairman o Leading Edge Medical, announced today that LEmed has
connected with the irst stem cell " TCM clinic in the world. #egenerati$e Medical %nstitute (#M%)
o Ti&uana, Me'ico, ully licensed by the go$ernment o Me'ico, has surprised the medical world by
leading the way.
Leading the #M% team is Dr. (ector )epeda. (is more than *+ years o e'perience in innate and
adapti$e immunology, as well as his e'perience at the ,asteur %nstitute and the -arolins.a %nstitute,
pro$ided the basis or the de$elopment o this new orm o therapy, rom which was created and
patented /T Cell Modulator0 or TCM!. T Cell Modulator (TCM!) is a leu.ocyte e'tract
manuactured by a proprietary methodology. Therapeutic eects o TCM ha$e pre$iously been
demonstrated in immunologically mediated conditions, as well as oncology.
TCM! has been shown to act directly upon Toll Li.e #eceptors, which ha$e been shown to be an
important actor in protecting stem cells in their new en$ironment, as well as promoting their
unction. /%n response to TL# stimulation human 1D-M2Cs induce the e'pression o manganese
supero'ide dismutase (Mn23D), a .ey protecti$e protein against o'idati$e stress in the
mitochondria4567. %t has been reported that induction o Mn23D protects cells rom o'idati$e stress
leading to increased sur$i$al4587. %n the settings o an inlammatory response, immune cells release
$ast amounts o reacti$e o'ygen species which results in the generation o an o'idati$e milieu.
9ased on these data we speculated that increased e'pression o Mn23D by M2Cs in response to
TL# ligand e'posure would pro$ide them with impro$ed engratment or sur$i$al at in&ured or
inlamed sites, leading to enhanced therapeutic eects.
#M% now &oins clinics in the Middle East and in Thailand, both using 1dult 2tem Cells and Laser
Therapies in combination, thus bringing our count o Double Clinics to three,: announced Mr.
Margolis.
;e e'pect to add another Double Clinic beore the end o *+56 to bring our total to our. #apid
ad$ancement, considering there was only one at the end o *+5<:
Currently, adult stem cell treatment is being used to help patients reco$er rom o$er 58+ debilitating
chronic conditions pre$iously thought to be untreatable, including the /9ig Three0 = (eart Disease,
Diabetes, and Lung Disease -- as well as 1ta'ia, ,ar.inson>s, 2pinal Cord %n&ury, Cerebral ,alsy,
Multiple 2clerosis, 1rthritis, and 1utism.
Contact&
?eery Tobin
Leading Edge 'edical, Ltd(
56@, A (ennessy #oad
China (ong -ong Tower
;an Chai, (ong -ong, BBB+CC
"A8* *5*C +DA6
inoEhealingmed.com
httpFGGwww.healingmed.com